BRAEMAR UNVEILS ER920W WIRELESS CARDIAC MONITOR.
The ER920W connects the patient to a 24/7 monitoring center. Its telecommunications architecture, including cellular network, Internet and Braemar's proprietary LINX Management software interface, allows for bidirectional data flow, so the physician can monitor the patient's cardiac events and remotely program the device as required. The cellular transmitter embedded in the ER920W uses a "Quad-Band" modem for maximum flexibility and is compatible with both GSM and GPRS cellular networks.
"The ER920W is an advanced arrhythmia monitor with proprietary technology that we believe represents the next generation of cardiac event monitoring," Harry Strandquist, president of Braemar, Inc. said. "The ER920W provides faster patient diagnosis, improves patient compliance and is far superior to the current cumbersome transmission method. This device is the first in a series of Braemar wireless arrhythmia monitoring products currently under development."
Cardiac arrhythmia monitors are worn by patients for up to 30 days to document and record transient cardiac events. Recording of symptomatic events such as syncope, palpitations, dizziness, chest discomfort and shortness of breath is activated by the patient. The ER920W enhances diagnostic yield with embedded algorithms that automatically detect, record and immediately transmit asymptomatic events such as atrial fibrillation, bradycardia, tachycardia and cardiac pause.
Braemar, Inc., designs, develops, engineers and manufactures ambulatory cardiac monitoring and other medical devices. The company provides high-quality, reliable devices to OEM partners worldwide.
For more inforamtion call 651/286-8620 or visit http://www.biotelinc.com.
|Printer friendly Cite/link Email Feedback|
|Publication:||Modem User News|
|Date:||Jul 1, 2008|
|Previous Article:||AWARE EXPANDS DSL TEST MODEM MODULE PORTFOLIO.|
|Next Article:||CRICKET LAUNCHES UNLIMITED WIRELESS SERVICES.|